eTheRNA
Professor Kenneth Chien is a self-investor to eTheRNA and has been an Advisor to EQT since 2020. Kenneth is a Co-Founder of Moderna Therapeutics, and has served as a senior consultant and advisory board member to several biotechnology and large pharmas, including Genentech, Roche, GSK, Wyeth, and Pfizer.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
eTheRNA
eTheRNA is developing innovative immuno-oncology therapies based on its unique APC-activating messenger RNA platform.